The BlastGen study: A randomised controlled trial of GM-CSF supplemented blastocyst media

ConclusionThis study demonstrated a significant reduction in Day 5 embryo outcome parameters using Embryogen®/BlastGen™ compared to standard medium, and insufficient evidence of a difference in pregnancy outcomes. Taking into consideration the small samples size, study limitations, and strict inclusion criteria of this single-centred study, further research is necessary to determine the efficacy of Embryogen®/BlastGen™ medium in couples undergoing IVF/ICSI.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research